We are live on ! Find out more
IVF icon

INVO Fertility Inc

7 hedge funds and large institutions have $195K invested in INVO Fertility Inc in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

11.47% less ownership

Funds ownership: 17.28% → 5.8% (-11%)

30% less funds holding

Funds holding: 10 → 7 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

98% less capital inflows, than outflows

Capital inflows: $19.4K | Capital outflows: $959K

Holders
7
Holders Change
-3
Holders Change %
-30%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IVF Hedge Fund Activity: Q2 2023 in Review

7 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in INVO Fertility Inc (IVF) for Q2 2023, worth a combined $195K — down 87% from $1.54M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of IVF and 2 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $9.7K. The largest seller was Armistice Capital, exiting entirely with an estimated $882K sold.

  • 7 institutional investors held INVO Fertility Inc (IVF) as of Q2 2023, down from 10 in Q1 2023.
  • Funds reported $195K of INVO Fertility Inc stock for Q2 2023, down 87% quarter-over-quarter.
  • 2 funds opened new INVO Fertility Inc positions in Q2 2023 and 5 closed out, a net change of -3 holders.
  • The largest INVO Fertility Inc buyer in Q2 2023 was Renaissance Technologies, an estimated $9.7K added.
  • The largest INVO Fertility Inc seller in Q2 2023 was Armistice Capital, an estimated $882K sold.

Based on aggregated 13F filings for Q2 2023.